Patient Transportation Market Projected to Grow to USD 37,639.9 Million by 2034 at a 5.5% of CAGR

Patient Transportation Market
Patient Transportation Market

The global patient transportation market is on a robust growth trajectory, with an estimated valuation of USD 22,035.5 million in 2024. The market is expected to expand significantly, reaching USD 37,639.9 million by 2034, reflecting a compound annual growth rate (CAGR) of 5.5% over the forecast period.

In 2023, the revenue generated from non-emergency patient transportation reached USD 20,886.8 million, highlighting the substantial role this segment plays within the broader patient transportation industry. The sector is anticipated to experience a year-over-year growth rate of 5.5% in 2024, driven by increased demand for both emergency and non-emergency transportation services.

Because of efficiency in the management of critical care and long-term care patients in mobility, positioning, and transfer, sales in the market are expected to grow. Apart from that, chronically ill patients are given alternatives for transportation to and from medical facilities. These instances are provisional, based on reimbursements for patient transportation equipment capabilities, as determined by the patient’s insurance coverage, or government-funded initiatives.

The market for patient transportation is likely to gain traction, especially with the high prevalence of chronic diseases, high volumes of trauma-related cases, and disabilities. In cases where bariatric and diabetic patients require caregiver assistance for mobility, patient transportation solutions provide assistance.

To offer a diverse product range, manufacturers in the patient transportation market are developing products which are engineered as per disease indication. Key competitors have maintained a leading position in the market by integrating smart technologies into existing product offerings. 

Several firms are also promoting equipment sales through integration and collaboration with medical service providers, such as hospitals, which in turn is expected to boost sales in the market over the forecast period.

“Rising availability of indication-specific patient transportation solutions, along with the integration of connective technology such as artificial intelligence (AI) and IoT in beds and chairs will push sales in the market in the forthcoming years,” says an FMI analyst.

Key Takeaways:

  • Based on application, the non-emergency transportation held about 47.4% of the total market share in 2021, and the trend is expected to continue over the forecast period. 
  • In terms of end users, the hospitals segment accounted for 45.9% of the total market share in 2021. 
  • Sales in the U.S. patient transportation market are projected to increase at a 6.3% CAGR over the assessment period. 
  • Germany will witness high demand for patient transportation solutions, rising at a 6% CAGR through 2032. 
  • China will continue dominating the East Asia patient transportation market, with sales growing at a 5.9% CAGR over the forecast period. 

Competition Landscape 

Key players operating in the global patient transportation market are improve their product portfolios by incorporating breakthrough technologies for comprehensive patient care throughout the transportation process. In addition to this, the newly developed products can be personalised for use in response to certain disease-related events. For instance:

  • Stryker launched the industry’s first linked ambulance cot in March 2022, building on the success of its predecessor, the Power-PRO 2 powered ambulance cot. Greater manoeuvrability, improved safety, and connectivity tools are all part of the new development, which will help to mitigate time and cost constraints.
  • In December 2021, Vendlet launched a new powered patient turning aid.

Key Players :

  • Envision Healthcare
  • London Ambulance Service NHS Trust
  • Acadian Ambulance Service
  • BVG India Limited
  • America Patient Transport Services, Inc
  • Falck Denmark A/S
  • Air Medical Group Holdings, Inc.
  • Air Methods Corporation
  • Ziqitza Healthcare Limited
  • Medivic Aviation

A Old Full Report Analysis Click Here

Market Segments Covered in Patient Transport Services Market Analysis

By Transport Vehicle:

  • Ground Ambulance
  • Air Ambulance
  • Water Ambulance

By Emergency Services Type:

  • Emergency Services
  • Non-emergency Services

By Equipment Type:

  • Advanced Life Support (ALS) Patient Transport Services
  • Basic Life Support (BLS) Patient Transport Services

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Alzheimer’s Therapeutics Market Projected to Reach USD 7,359.7 Million by 2033 at a 9.2% of CAGR

Global Alzheimer’s Therapeutics Industry
Global Alzheimer’s Therapeutics Market

The global Alzheimer’s therapeutics market is on a strong growth trajectory, with an expected valuation of USD 3,052.3 million in 2023. According to recent forecasts, the market is set to expand at a compound annual growth rate (CAGR) of 9.2%, reaching a substantial USD 7,359.7 million by 2033.

Alzheimer’s disease, a progressive neurological disorder that affects millions worldwide, has driven an increasing demand for effective therapeutics. The projected market growth reflects the ongoing advancements in drug development, heightened investment in research, and the urgent need for innovative treatments to manage and potentially cure this debilitating condition.

Therapies for Alzheimer’s therapeutics offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease Alzheimer’s Therapeutics cement. Thus, the magnitude of the affected population and the lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers.

However, the identification of the primary reasons and mechanisms involved in Alzheimer’s therapeutics is limited. Drug manufacturers have been unable to validate the significant clinical benefits of treatment for numerous new compounds due to strict regulations. One of the significant trends observed in this market is the collaboration of the existing players.

Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates, which is further expected to propel the demand.

Developing countries are expected to offer lucrative opportunities for this market. According to Alzheimer’s Therapeutics International in 2015, 58% of people with dementia live in developing countries, but by 2050 this will rise to 68%. The fastest growth in the elderly population is taking place in China, India, and their South Asian and Western Pacific region.

According to the World Alzheimer Report in 2015, regional estimations of dementia prevalence in people aged 60 years and over vary from 4.6% in Central Europe to 8.7% in North Africa and the Middle East, however, all other regional estimates fall in relatively between 5.6% and 7.6%.

The top 17 Key Players Covered in the Alzheimer’s Therapeutics Market are:

  1. AbbVie, Inc.
  2. Teva Pharmaceuticals Ltd.
  3. Eisai Co., Ltd.
  4. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
  5. Novartis AG
  6. Zydus Lifesciences Ltd (CADILA)
  7. Sun Pharmaceutical Industries Ltd.
  8. Dr. Reddy’s Laboratories Ltd
  9. Aurobindo Pharma Ltd
  10. Amneal Pharmaceuticals Inc.
  11. Macleods Pharmaceuticals Ltd.
  12. Viatris Inc.
  13. Lupin Ltd
  14. Cipla Ltd.
  15. Torrent Pharmaceuticals Ltd.
  16. Unichem laboratories ltd
  17. Lannett Inc.

A Old Full Report Analysis Click Here

Key Segments Covered in Alzheimer’s Therapeutics Market Research

By Drug Name:

  • Donepezil
  • Rivastigmine
  • Memantine
  • Galantamine
  • Manufactured a combination of memantine and donepezil

By Drug Class:

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Manufactured Combination

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Extraction Kits Market Poised for Robust Growth, Projected to Reach USD 2,556.6 Million by 2033 at a 7.1% of CAGR

Extraction Kits Market
Extraction Kits Market

The global extraction kits market is set for significant expansion, with an anticipated growth rate of 7.1% CAGR over the forecast period. The market size is estimated to reach a substantial valuation of USD 1,293.4 million by the end of 2023.

A recent study highlights that DNA extraction kits are a major driver of this growth, holding a notable 49.88% share of the global market in 2022. The dominance of DNA extraction kits underscores their critical role in various applications, including medical research, diagnostics, and biotechnology.

Moreover, an upsurge in the number of research and development activities that focus on developing the fastest vaccines to combat various infectious diseases will further prompt growth in the target market. In addition to this, several other initiatives like the EMBO, and Young Investigator Program assists with the establishment of laboratories by life scientists. All similar research initiatives will support the leading market players to develop their businesses in emerging economies, attract lucrative opportunities, and invite overall target market growth during the forecast period.

“Increasing funding in life sciences and investment for molecular diagnostics will generate growth opportunities for the global extraction kits market over the forecast period,” says an FMI analyst.  

Key Takeaways:

  • Dearth of expert personnel and strict regulatory measures may stymie the market growth.
  • The U.S’s extraction kits market is predicted to present notable growth during 2022-2032.
  • The extraction kits market in Germany will register a CAGR of 8.3% during the forecast period.
  • China’s extraction kits market will grow at a CAGR of 9.7% during 2022-2032.
  • The DNA extraction kits segment accounted for 49.7% of the market share and will grow at 7.4% CAGR during the assessment period.
  • On the basis of application, the disease diagnosis segment will account for 36.0% revenue share.

Competitive Landscape in the Global Extraction Kits Industry 

  • Bio Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bioneer Corporation
  • PerkinElmer Inc.
  • LGC Biosearch Technologies
  • Qiagen
  • General Biosystems
  • Takara Bio Inc.
  • Roche Life Science
  • GeneReach Biotechnology Corporation.
  • Merck Millipore
  • BioFire Defense LLC
  • Akonni Biosystems, Inc
  • Primerdesign Ltd.

Key market participants are concentrating on increasing their sales in emerging economies. These enterprises are keen on new product releases and strategic collaboration to improve their revenue.

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global Extraction Kits Industry Research

By Product:

  • DNA Extraction Kits
    • Sequence-specific DNA
    • Cell-free DNA (cfDNA)
    • Tissue DNA Extraction Kits
  • RNA extraction Kits
    • Total RNA
    • Purified RNAs
    • Viral RNA
    • Sequence-specific RNA
  • Total nucleic acid (RNA + DNA)

By Application:

  • Disease Diagnosis
  • Drug Discovery
  • Cancer Research
  • cDNA Library
  • Others

By End User:

  • Hospitals
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Clinical Research Organisations
  • Diagnostic Laboratories
  • Forensic Labs

 Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Bacteriophage Market Set for Steady Growth, Projected to Reach USD 68 Million by 2033 at a 4.2% of CAGR

Bacteriophage Market
Global Bacteriophage Market

The global bacteriophage market is experiencing notable momentum, with a current valuation of USD 45.07 million in 2023. According to recent projections, the market is expected to grow steadily, reaching USD 68 million by 2033. This growth is anticipated at a compound annual growth rate (CAGR) of 4.2% over the forecast period.

Bacteriophages, or phages, are viruses that target and destroy specific bacteria, offering a promising alternative to traditional antibiotics, particularly in the face of rising antimicrobial resistance. As the global healthcare industry increasingly turns to innovative solutions to combat bacterial infections, the demand for bacteriophage-based therapies is gaining momentum.

Phage probiotics are increasingly in demand since they have many advantages over conventional probiotics. This is driving the market’s expansion. In order to maintain a healthy gut, phage probiotics encourage the growth of beneficial gut bacteria over bad gut bacteria. The market is expanding more rapidly as novel treatment options for infections caused by bacteria resistant to antibiotics are being developed. Growing public knowledge of the use of bacteriophage probiotics for those with immune-mediated digestive problems and bowel problems will also help the industry.

Surging demand for phage probiotics has encouraged the key players in the market to up their game by increasing investment in research and development (R&D) for new bacteriophages. In comparison to antibiotics, bacteriophages possess high host specificity, they exhibit good benefits with single hit kinetics, are self-replicating and also possess anti-biofilm properties.

As per FMI, gastroenterology is the most sought after application of phage probiotics, as phage probiotics are administered by doctors since phage therapeutics do not get early clearance from regulatory authorities in many developing regions.

Bacteriophage probiotics are mostly administered via the oral route since it is non- invasive, shows immediate release and is cost effective. These probiotics are widely available in retail pharmacies, thereby, boosting the sales in developing nations.

Key Takeaways from Market Study

  • Phage probiotics are expected to hold over 95% market value share in 2021, and are expected to display a CAGR growth of 4.2% over the forecast period.
  • The oral route of administration accounted for over 96% of market share in 2021 and is expected to hold a market share by value of 97.2% by 2031.
  • In terms of application, gastroenterology registered growth at a CAGR of 4.3% in 2021, with a market share of 93.8%.
  • Retail pharmacies will hold a higher share in the bacteriophage market due to presence of large chain of retail pharmacies and easy availability of pharma products
  • Europe is slated to be the largest leading region with a value share of 43% by the end of the forecast period due to presence of large healthcare infrastructure and strong R&D centers.

“With rising prevalence of antibacterial resistance, the bacteriophage market is expected to witness steady growth over the forecast period. To curb the global burden, key players are likely to invest extensively in R&D activities to develop effective phage probiotics” says an analyst of Future Market Insights.

Market Competition

Acquisitions, expansion, development of an extensive product pipeline and product launches are the key strategies adopted by manufacturers to increase their revenue and expand their consumer base in different geographies.

  • In August 2021, Carillon Miami Wellness Resort partnered with the biostation to launch a new functional medicine practice located at the resort’s award-winning, 70,000-square-foot spa and wellness facility.
  • In February 2020, Microgen’s Bacteriophage products have been included into clinical recommendations for urology.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global bacteriophage market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on bacteriophage market segment based on product – (phage probiotics, phage therapeutics), by route of administration- (oral, topical, others), by application (gastroenterology, respiratory infections treatment, skin infection treatment, wound prophylaxis, urogenital infection treatment, others), by distribution channel (retail pharmacies, hospital pharmacies, online pharmacies) and across seven major regions.

Key Players:

  • Life extension
  • Arthur Andrew Medical
  • Deerland Probiotics & Enzymes Inc.
  • BioChimpharm
  • Micreos Human Health
  • Designs for Health
  • Accelerated Health Systems LLC
  • The biostation
  • Microgen
  • IntraLytix Inc.

A Old Full Report Analysis Click Here

Key Market Segments Covered In Bacteriophage Industry Research

By Product:

  • Phage Probiotics
  • Phage Therapeutics

By Route of Administration:

  • Oral
  • Topical
  • Other

By Application:

  • Gastroeneterology
  • Respiratory infections market
  • Skin infection treatment
  • Wound prophylaxis
  • Urogenital infection treatment
  • Others

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

eClinical Solutions and Software Market Poised for Exponential Growth, Anticipates USD 29.1 Billion Valuation by 2033 at a 12.1% of CAGR

Global eClinical Solutions and Software Industry
Global eClinical Solutions and Software Market

The global eClinical Solutions and Software Market set to achieve a remarkable valuation of USD 9.3 billion by the end of 2023, with projections indicating a substantial expansion at a compound annual growth rate (CAGR) of 12.1%. By 2033, the market is expected to reach a staggering USD 29.1 billion, according to a recent study by Future Market Insights.

One of the key drivers behind this impressive growth is the dominance of Clinical Data Management Systems (CDMS), which are anticipated to hold a notable 22.6% share of the global market in 2023. CDMS play a crucial role in streamlining clinical trials and managing large volumes of data, enhancing the efficiency and accuracy of clinical research processes.

The significant market expansion reflects increasing investments in healthcare technology, a growing demand for data-driven decision-making, and a rising emphasis on the digitization of clinical data management. As organizations and institutions strive to improve research outcomes and operational efficiency, CDMS has emerged as a pivotal component in the evolving landscape of clinical research and development.

The expansion of research and development activities by biopharmaceutical and pharmaceutical businesses will prompt the use of eClinical solutions and software in various clinical trials which will foster growth for the market. This is primarily due to the fact that in order to address certain contemporary eClinical trial management needs, many businesses will require a comprehensive eClinical platform that will adapt to required needs. Hence, the prospects for the Global eClinical Solutions and Software Industry look bright in the upcoming years.

With the surge in the amount of data produced via the clinical development process, the need for efficient tracking and evaluation of clinical data will also rise. As a result of this, the demand for eClinical solutions and software amplifies in clinical trials which, in turn, supplements the overall market growth. The eClinical solutions and software increase efficiency, lessen the expenditure, and errors like duplicate entry are avoided due to the use of eClinical technologies. This factor bodes well for the expansion of the Global eClinical Solutions and Software Industry size. Other factors that will aid the market growth are the progress witnessed in the life sciences field and the outsourcing of clinical trials to contract research organizations (CROs). All of these factors propel the Global eClinical Solutions and Software Industry forward during the projection period.

Key Takeaways:

  • High costs and constant maintenance expenditure will prevent the growth of the eClinical solutions and software market during the assessment period.
  • Based on the service, the clinical data management systems (CDMS) category will dominate the global market with an estimated share of 22.6% for 2023 and 2033.
  • By delivery mode, the web-hosted (on-demand) will lead the market with a share of 67.3%.
  • The eClinical solutions and software market in the US will hold about 39.3% of the market share in 2023 due to increasing product launches by key players.
  • China’s eClinical solutions and software market will expand at a strong CAGR of 8.7% owing to greater medical needs.

Competitive Landscape 

Oracle, Datatrak International, Inc., CRF Health, eClinicalWorks, Parexel International Corporation, Bioclinica, IBM Watson Health, and Anju Life Sciences Software, among others, are some of the dominant players in the Global eClinical Solutions and Software Industry profiled in the full version of the report.

In an intensely competitive environment, leading market players are concentrating on the swift adoption of advancing technology. These businesses employ various expansion strategies including mergers, collaborations, partnerships, and acquisitions, while also engaging in product development to enhance their market positions.

More Insights Into Global eClinical Solutions and Software Industry

In its latest report, FMI offers an unbiased and detailed analysis of the Global eClinical Solutions and Software Industry, providing historical data from 2017 to 2022 and forecast statistics for 2023 to 2033. For a comprehensive understanding of the global market potential, growth, and scope, the market is segmented on the basis of solution, delivery mode, clinical trial, end-user, and region.

According to the same reports, based on segmentation, the CROs category will make substantial contributions to the overall market growth in terms of end-users. In terms of clinical trials, the phase III segment will account for 46.7% of the global market share in 2023.

Based on region, the Global eClinical Solutions and Software Industry will present strong growth in the US. The target market in this region will account for 39.3% of the market share in 2023 and will likely continue this growth during the forecast period. Favorable government policies and rising funds from the government as well as increasing product launches from key players will push the market forward in the US. Germany and China, too, will make notable contributions to the global growth of the eClinical solutions and software market during the forecast period.

Key Players:

  1. Oracle
  2. Datatrak International, Inc.
  3. Dassault Systemes
  4. CRF Health
  5. eClinicalWorks
  6. Parexel International Corporation
  7. Bioclinica
  8. eClinical Solutions
  9. IBM Watson Health
  10. Anju Life Sciences Software
  11. ERT Clinical

A Old Full Report Analysis Click Here

Key Market Segments Covered in Global eClinical Solutions and Software Industry Research

Solution:

  • Randomization & Trial Management (RTSM)
  • Clinical Data Management System (CDSM)
  • Clinical Trial Management System (CLMS)
  • Electronic Clinical Outcome Assessment (eCOA)
  • Electronic Trial Master File (eTMF)
  • Electronic Data Capture
  • Others

Delivery Mode:

  • Licensed Enterprise (On-premise) Solution
  • Cloud-based (SAAS) Solution
  • Web-hosted (on-demand) Solution

Clinical Trial:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Acute Kidney Injury Treatment Market Set for Remarkable Growth to an Impressive USD 3,566.7 Million by the End of 2029 with 8.2% CAGR

Acute Kidney Injury Treatment Market
Acute Kidney Injury Treatment Market

The global Acute Kidney Injury Treatment Market is poised for extraordinary expansion, with a projected compound annual growth rate (CAGR) of 8.2% from 2022 to 2029. This growth is driven by increasing awareness, advancements in medical technologies, and a rising global incidence of acute kidney injuries.

The market’s value is anticipated to soar from over USD 2,058.2 million in 2022 to an impressive USD 3,566.7 million by the end of 2029. This substantial increase reflects the heightened demand for innovative treatment options and the ongoing development of cutting-edge therapies aimed at addressing this critical health condition.

Acute Kidney Injury, a sudden loss of kidney function that can occur due to a variety of causes including injury, infection, or complications from other conditions, presents a significant healthcare challenge. The growing prevalence of this condition globally, combined with the introduction of advanced treatment modalities and supportive technologies, is driving market growth.

Industry experts attribute this robust market trajectory to several factors, including increased investment in research and development, enhanced diagnostic and monitoring technologies, and a surge in the number of patients requiring specialized care. Furthermore, the rise in geriatric populations and chronic diseases that predispose individuals to AKI are expected to further fuel demand for effective treatment solutions.

Key Takeaways:

  • Owing to increasing acute kidney injury prevalence, number of dialysis centres, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
  • The intermittent haemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
  • The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
  • North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

The participants in the acute renal injury treatment market are keeping up with advances in diagnostic technology and increased product availability in order to streamline their product offerings in respective regions with different product portfolios. For example, Fresenius Medical Care introduced the 4008A dialysis equipment in January 2022 in an effort to provide accessibility to dialysis treatment that is life-sustaining.

Competitive Landscape:

To provide patients with cutting-edge care, major companies in the worldwide acute renal injury treatment market are concentrating on creating automated, mobile, and tech-driven dialysis equipment. In order to broaden their range of products, they are also using cutting-edge technology like artificial intelligence and the Internet of Things (IoT).

In the meantime, several of the other firms are developing diagnostic technologies to simplify their product offers in emerging markets where their product portfolios are diversified.

For instance:

  • In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
  • In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.

Key Companies Profiled:

  • Novartis, Pfizer Inc.
  • Merck & Co.
  • Biocon Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.
  • NIPRO Medical
  • Baxter Corporation
  • Asahi Kasei
  • NIKKISO
  • Fresenius Medical Care
  • Others

A Old Full Report Analysis Click Here

Acute Kidney Injury Treatment Market By Category:

Product:

  • Dialysis
    • Intermittent Hemodialysis
    • Continuous Renal Replacement Therapy (CRRT)
    • Sustained Low-Efficiency Dialysis (SLED)
  • Drug Therapy
    • Antibiotics
    • Diuretics
    • Immunosuppressive Agents

Injury:

  • Pre-renal Injury
  • Intrinsic Renal Injury
  • Post-renal Injury

Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Telemedicine Equipment Market Set to Surge from USD 3.5 Billion in 2021 to expected valued at USD 10,267.2 Million by 2028 at a 17.3% of CAGR

Telemedicine Equipment Market
Telemedicine Equipment Market

The telemedicine equipment market, valued at over USD 3.5 billion in 2021, is projected to experience significant growth at a compound annual growth rate (CAGR) of 17.3% throughout the forecast period.

It is due to cost-shifting from government programmes to private payers. Low reimbursement rates of telehealth machine and telemedicine machine have exacerbated the cost-shifting burden on hospitals and doctors, who charge higher fees to private payers for the same facilities, affecting health insurance premiums.

Telemedicine has decreased healthcare costs while boosting efficiency through improved chronic illness management, reduced travel times, pooled health professional staffing, and fewer and shorter hospital stays. Just because of these reasons, the telemedicine equipment market is likely to develop rapidly throughout the forecast period.

The increase of chronic illnesses is a worldwide problem that strains healthcare resources.

Tele-homecare is a novel approach to providing care, monitoring a patient, and disseminating information that makes use of cutting-edge telecommunications technology.

Monitoring provides for the early detection of illnesses and the prevention of chronic problems.

Telemedicine is a fast-developing component of healthcare in the United States, owing to the country’s high adoption of innovative healthcare technology and the growing burden of chronic illnesses. Telemedicine adoption has improved care management, patients’ quality of life, and healthcare costs.

Rising demand for mobile technologies increased patient adoption of home care, and a reduction in hospital visits are likely to drive telemedicine equipment market growth throughout the forecast period.

The rise of telemedicine apps that assist Americans in becoming engaged in personal health management, particularly during the present COVID-19 pandemic, is a good trend in healthcare in the United States.

  • Estshara, a Cairo-based firm that provides an online platform for health consultations and tele pharmacy services, received USD 500,000 in early investment from Egypt Venture in July 2021. The firm presently has over 2 million users and a track record of over 200,000 consultations.
  • MediTelecare will launch “MediTely” on the market in May 2021. It is a direct-to-consumer mobile health technology aimed at the elderly population who live outside of long-term care institutions.
  • Teladoc Health joined forces with Vivo in May 2021 to expand access to excellent healthcare in Brazil, notably through the use of telemedicine.
  • Kry, a Swedish digital health start-up that provides telehealth services and software solutions to link physicians with patients for remote consultations, funded EUR 312 million in April 2021. Its telehealth platform and software solutions are used by around 6,000 practitioners.
  • AMD Global announced its merger with PointClickCare Technologies, the global leader in cloud-based software solutions for the long-term and post-acute care (LTPAC) sector, in March 2021.
  • BioTelemetry Inc. and Royal Philips agreed to a final merger agreement in December 2020.
  • Morneau Shepell will introduce its first unified telemedicine solution in the United States in November 2020.

A Old Full Report Analysis Click Here

Key Market Segments

By Product:

  • Telemedicine cart
    • Single display cart
    • Dual display cart
    • Others
  • Telemedicine kit
  • Telemedicine kiosk
  • Peripherals
    • Digital camera
    • Stethoscopes
    • Digital scopes
    • Pulse oximeters
    • Others

By End Use:

  • Hospitals
  • Clinics
  • Specialty centers
  • Home care settings
  • Others

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Vehicle Radar Test Systems Market 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

The overall vehicle radar test systems market is presumably going to be regarded at US$ 4128.0 million out of 2022 and is expected to get a strong CAGR of 12.1% through 2032. The interest in vehicle radar test systems should create a value of US$ 12,986 million by 2032.

Growing foundations of radar sensors and ADAS (undeniable level driver help systems) sub-systems have provoked the introduction of Vehicle Radar Test Systems (VRTS) as Vehicle Radar Test Systems. This structure can be used for RF assessment and for testing both gear and programming subsystems of an auto including introduced programming, ADAS systems, and radar sensors.

Vehicle radar test structure effectively plans advanced ADA systems to deal with vehicles’ security and enduring nature. Vehicle Radar Test Systems enable modernized radar assessment and tangle generation capacities concerning vehicular radar systems (the repeat changes with various VRTSs). For instance, the NI Vehicle radar test structure coordinates with vehicular radar systems working more than 7 to 81 GHz repeat.

A Vehicle Radar Test System assists an expert during a radar structure improvement with handling — from its R&D to its high-volume delivering test and enables him to pass strong free driving development on to adjust to creating regulatory necessities.

Vehicle Radar Test System Market: Drivers and Challenges:
Change from hindrance age for useful conduct testing, as empowered by customary auto radar test systems, to dynamic obstruction age and extensive RF trademark estimations is supposed to drive the interest in vehicle radar test systems.

The vehicle radar test framework’s element of consolidating and synchronizing with other estimation equipment all the while reproducing numerous sensor types, in sensor combination testing applications, likewise goes about as a driver for the equivalent.

The worldwide extension and reception of radar sensors simultaneously support the interest in Vehicle Radar Test Systems, going as an essential driver for the worldwide Vehicle Radar Test System market. Moreover, the normal presentation of completely mechanized vehicles in the gauge period will likewise drive the general Vehicle Radar Test System Market.

The essential variable hampering the development of the Vehicle Radar Test System is the intricacy related to its establishment. Coordination of the radar module into a vehicle’s foundation,, amounts to intricacy. Furthermore, the significant expense related to vehicle radar test framework goes about as a controlling component for the development of the worldwide vehicle radar test framework’s market.

Leading Key Players:
Some of the key players in the Vehicle Radar Test System market are National Instruments, NOFFZ Technologies, Konrad GmbH, KEYCOM Corp., SAE International, and Anritsu Corporation.

In October 2017, NOFFZ Technologies partnered with National Instruments to provide the NI Vehicle Radar Test System (VRTS).

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights

Key Segments in the Vehicle Radar Test Systems Market

By Components:

  • VST (Vector Signal Transceiver)
  • VDG (Variable Delay Generator)
  • PXI Controller
  • Antennae

By Application:

  • Research and Development
  • Radar Module Manufacturing
  • Vehicle Manufacturing
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Middle East and Africa (MEA)
  • Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Smart Electric Meter Market 2022 Future Analysis, Demand by Regions and Opportunities with Challenges 2032

The market for smart electric meters is anticipated to grow at a rate of 10.0%, with a projected value of US$ 20,983.3 million by 2022. The market is expected to be valued US$ 54,254.7 million by 2032.

Global demand for smart electric meters has grown as a result of the rising need for accurate billing and energy-saving measures. The business environment for the market for smart electric meters has further improved due to the electrical network’s quick growth and the rise in smart grid expenses. Utility firms can increase revenue collection by improving billing accuracy through the use of smart electric meters.

A recent development in the market for smart electric meters is the demand for these devices in distribution, automation, and renewable energy integration applications. The market’s demand for smart electric meters will further rise as a result of a future project on electric vehicle fuel.

Smart electric meter Market: Drivers and Challenges

The increase in electricity demand is driving the growth of the global smart electric meter market as governments use the technology to reduce energy consumption and make use of available energy to improve access to electricity for people in areas not connected to grid power. Increasing energy prices and growing instances of electricity theft is also a driver which will further boost Smart electric meter demand.

The wireless signals from these smart electric meters lead to health problems making this a major challenge in the market. Other challenges for the smart electric meter market would include regulatory constraints and fierce competition among other players in the global smart meter market.

Smart electric meter Market: Competition Landscape

Key Contracts:

In June 2017, Comverge a company famous for its integrated cloud-based demand response, energy efficiency, and customer engagement solutions was acquired by Itron which provides solutions to measure, manage and analyze energy and water through smart electric meters and smart meters.

In September 2015, Aclara acquired General Electric’s electricity metering business. The acquisition strengthened Aclara’s position in the smart electric meter market. Aclara is famous for its metering in the North American region specifically.

Key Players

Major industry participants in the Smart electric meter market include Seimens, Itron, Schneider Electric, Landis+GYR, Holley Metering, Iskraeeco, Osaki Electric, Sensus Sentec, Neptune Technology, Honeywell International, Badger Meter, Elster Group and Tableau Software among others.

Regional Overview

North America is expected to be the largest market for Smart electric meters due to major growth in the market. The main reason for this is the growth in infrastructure, strict government policies, and the emergence of smart cities.

Asia Pacific is expected to manifest high growth over the foreseeable future. Europe and the Middle East and Africa can be seen emerging in this market.

Key Segments in the Smart Electric Meter Market

By Product:

  • Smart Electric Meter
  • Smart Water Meter
  • Smart Gas Meter

By End-Use:

  • Residential
  • Commercial
  • Industrial

By Phase:

  • Single
  • Three

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • META
  • Europe

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automotive Engineering Services Outsourcing Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

The global automotive engineering services outsourcing market size is set to reach US$ 94.38 billion in 2023. Overall sales of automotive engineering services outsourcing are likely to surge at 11.2% CAGR, taking the forecasted market valuation to US$ 272.84 billion by the end of 2033.

The automotive engineering services outsourcing market is poised for significant growth, driven by the increasing technological skills of Engineering Service Providers (ESPs) to deliver cutting-edge research and development (R&D) and product innovation for vehicle positioning, connected automobiles, and guidance systems. The outsource automotive engineering services market is also expected to benefit from the rising government initiatives to deploy green vehicles for reducing harmful gas discharges, further fueling its growth.

The automotive ESO industry has come a long way from delivering mechanical services to the integration of advanced technology solutions such as Artificial Intelligence (AI), the Internet of Things (IoT), and others. With the rapid integration of Information Technology (IT) in automobiles, an increase in advanced services was witnessed, accomplishing the commutation objectives and providing comfort, safety, and ease of use to the consumers. The IT-enabled the incorporation of various enhanced features such as Bluetooth and Wireless Local Area Network (WLAN) connectivity, navigation system, app connection, and other car information from sensors.

As customer requirements evolve, companies now emphasize offering mass customization of automobile production engineering services instead of mass production by combining standardization, synchronization, precision, continuity, and interchangeability. This is attributed to the growing inclination of Original Equipment Manufacturers (OEMs) for digitalized solutions, which is expected to offer opportunities for automotive ESO market growth. The Autonomous, Connected, Electric, and Shared vehicles (ACES) disruptions is a digitalized model being adopted by key players in the market to allow advanced mobility standards to enhance consumers’ interaction and experience with vehicles.

Autonomous driving has evolved through the Advanced Driver Assistance Systems (ADAS), including pedestrian detection, collision warning, and others. The connected systems enable processing data in the cloud and at the edge from a growing suite of endpoint sensors to enhance vehicle reliability and passenger safety, boost fleet efficiency, enable maintenance schedules, and offer information to smart city planners and other road users about the travel.

Key Takeaways

  • The automotive ESO market is expected to experience significant growth driven by the increasing technological skills of ESPs and rising government initiatives towards green vehicles.
  • The integration of advanced technology solutions such as AI, IoT, and others is driving the growth of the outsource automotive engineering services industry, providing comfort, safety, and ease of use to consumers.
  • Outsource automotive engineering services providers are shifting from mass production to mass customization of automobile production engineering services.
  • OEMs are emphasizing digitalized solutions and adopting models such as Autonomous, Connected, Electric, and Shared (ACES) vehicles to enhance consumer interaction and experience with vehicles.

Competitive Landscape

The competitive landscape of the automotive engineering services outsourcing market is highly fragmented, with many players operating in the market. The market is characterized by the presence of both multinational corporations and small and medium-sized enterprises (SMEs) offering a wide range of services to automotive Original Equipment Manufacturers (OEMs).

The top players in the market include companies like Capgemini SE, HCL Technologies, and Infosys Limited. These companies offer a broad range of services, including product design and development, testing and validation, and engineering analytics, among others.

There are several other players in the market, including global engineering service providers like Tata Technologies, AKKA Technologies, Alten Group, and others. Regional players such as QuEST Global, Mindtree Limited, and L&T Technology Services also have a significant presence in the market.

Key Segments

By Application:

  • Autonomous Driving/ADAS
  • Automotive Body & Chassis
  • Automotive Powertrain and After-Treatment
  • Automotive Infotainment & Connectivity
  • Others

By Service:

  • Automotive Designing
  • Automotive Prototyping
  • Automotive System Integration
  • Automotive Testing
  • Others

By Location:

  • On-shore
  • Off-shore

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube